Generated: April 30, 2017
|Title:||Method for treating T-cell lymphoblastic leukemia with ara-G nucleoside derivatives|
|Abstract:||6-Alkoxy derivatives of Ara-G, and pharmaceutically acceptable esters thereof, are described as being useful in tumor therapy. Novel pharmaceutically acceptable esters, their preparation and pharmaceutical formulations containing them are also disclosed.|
|Inventor(s):||Krenitsky; Thomas A. (Chapel Hill, NC), Averett; Devron R. (Raleigh, NC), Koszalka; George W. (Chapel Hill, NC), Wolberg; Gerald (Cary, NC)|
|Assignee:||Burroughs Wellcome Co. (141) (Research Triangle Park, NC)|
1. A method of treating T-cell lymphoblastic leukemia in a mammal having T-cell lymphoblastic leukemia which comprises administering to said mammal an effective T-cell lymphoblastic
leukemia treatment amount of the compound 9-.beta.-D-arabinofuranosyl-2-amino-6-methoxy-9H-purine.
2. A method of treating T-cell lymphoblastic leukemia in a mammal having T-cell lymphoblastic leukemia which comprises administering to said mammal an effective leukemia treatment amount of the compound 9-.beta.-D-arabinofuranosyl-2-amino-6-methoxy-9H-purine or a pharmaceutically acceptable salt thereof.
3. The method of claim 1 in which the compound is administered by injection.
4. The method of claim 2 in which the compound or salt thereof is administered by injection.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.